These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3461095)

  • 1. Prostaglandin E2 content of regressing and progressing Moloney sarcomas.
    Wechsler SJ; Eurell TE; Russell SW
    J Leukoc Biol; 1986 Aug; 40(2):159-68. PubMed ID: 3461095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory cells in solid murine neoplasms. II. Cell types found throughout the course of Moloney sarcoma regression or progression.
    Russell SW; Gillespie GY; Hansen CB; Cochrane CG
    Int J Cancer; 1976 Sep; 18(3):331-8. PubMed ID: 1085289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory cells in solid murine neoplasms. III. Cytotoxicity mediated in vitro by macrophages recovered from disaggregated regressing Moloney sarcomas.
    Russell SW; Gillespie GY; McIntosh AT
    J Immunol; 1977 May; 118(5):1574-9. PubMed ID: 870561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophages isolated from regressing Moloney sarcomas are more cytotoxic than those recovered from progressing sarcomas.
    Russell SW; McIntosh AT
    Nature; 1977 Jul; 268(5615):69-71. PubMed ID: 887150
    [No Abstract]   [Full Text] [Related]  

  • 5. Development and persistence of cytolytic T lymphocytes in regressing or progressing Moloney sarcomas.
    Gillespie GY; Russell SW
    Int J Cancer; 1978 Jan; 21(1):94-99. PubMed ID: 304846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory cells in solid murine neoplasms. IV. Cytolytic T lymphocytes isolated from regressing or progressing Moloney sarcomas.
    Gillespie GY; Hansen CB; Hoskins RG; Russell SW
    J Immunol; 1977 Aug; 119(2):564-70. PubMed ID: 301897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of macrophage-mediated tumor cell killing by prostaglandins: comparison of the effects of PGE2 and PGI2.
    Taffet SM; Eurell TE; Russell SW
    Prostaglandins; 1982 Dec; 24(6):763-74. PubMed ID: 6300968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nature, function and distribution of inflammatory cells in regressing and progressing Moloney sarcomas.
    Russell SW; Gillespie GY
    J Reticuloendothel Soc; 1977 Aug; 22(2):159-68. PubMed ID: 72153
    [No Abstract]   [Full Text] [Related]  

  • 9. Functional characterization of a stable, noncytolytic stage of macrophage activation in tumors.
    Russell SW; Doe WF; McIntosh AT
    J Exp Med; 1977 Dec; 146(6):1511-20. PubMed ID: 925611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Number of macrophages and distribution of mitotic activity in regressing and progressing Moloney sarcomas.
    Russel SW; Doe WF; Cochrane CG
    J Immunol; 1976 Jan; 116(1):164-6. PubMed ID: 1245738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gamma interferon interferes with the negative regulation of macrophage activation by prostaglandin E2.
    Russell SW; Pace JL
    Mol Immunol; 1984 Mar; 21(3):249-54. PubMed ID: 6425647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage-mediated tumor cell killing: lack of dependence on the cyclooxygenase pathway of prostaglandin synthesis.
    Shaw JO; Russell SW; Printz MP; Skidgel RA
    J Immunol; 1979 Jul; 123(1):50-4. PubMed ID: 109539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-T-cell-mediated cytotoxicity in MSV tumor-bearing mice. III. Macrophage-mediated cytotoxicity against autochthonous MSV tumor-isolated target cells.
    Becker S; Haskill S
    Int J Cancer; 1980 Apr; 25(4):535-41. PubMed ID: 6966262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of prostaglandins on the regulation of macrophage proliferation and cytotoxic functions.
    Meerpohl HG; Bauknecht T
    Prostaglandins; 1986 May; 31(5):961-72. PubMed ID: 2873629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophage-mediated suppression of natural killer cell activity in mice bearing Lewis lung carcinoma.
    Young MR; Wheeler E; Newby M
    J Natl Cancer Inst; 1986 Apr; 76(4):745-50. PubMed ID: 3457207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin E2 and plasminogen activators in human milk and their secretion by milk macrophages.
    Le Deist F; de Saint-Basile G; Angeles-Cano E; Griscelli C
    Am J Reprod Immunol Microbiol; 1986 May; 11(1):6-10. PubMed ID: 3461715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Both the kind and magnitude of stimulus are important in overcoming the negative regulation of macrophage activation by PGE2.
    Russell SW; Pace JL
    J Leukoc Biol; 1984 Mar; 35(3):291-301. PubMed ID: 6423750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymus-derived macrophages in long-term culture: release of IL-1, stimulation of MLR and expression of tumoricidal activity.
    Gallily R; Zeira M; Stain I
    Immunology; 1985 May; 55(1):165-72. PubMed ID: 3158594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage activation by granulocyte/macrophage colony-stimulating factor. Priming for enhanced release of tumor necrosis factor-alpha and prostaglandin E2.
    Heidenreich S; Gong JH; Schmidt A; Nain M; Gemsa D
    J Immunol; 1989 Aug; 143(4):1198-205. PubMed ID: 2473121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin E2 synthesis by human primary and metastatic bone tumors in culture.
    Gebhardt MC; Lippiello L; Bringhurst FR; Mankin HJ
    Clin Orthop Relat Res; 1985 Jun; (196):300-5. PubMed ID: 3858043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.